1 min read
Add as a preferred source on GoogleEQT AB Holds Advanced Talks to Acquire Testing Firm Qiagen N.V.
The Swedish investment firm has submitted an offer of more than $50 per share.
Swedish investment firm EQT AB was in advanced talks Tuesday, Oct. 20, to acquire Qiagen N.V. (QGEN), a European molecular testing company, after submitting an offer of more than $50 per share.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.